- Home
- FITB vs PODD Comparison
FITB vs PODD Comparison
Compare FITB & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FITB
- PODD
- Stock Information
- Founded
- FITB 1858
- PODD 2000
- Country
- FITB United States
- PODD United States
- Employees
- FITB N/A
- PODD N/A
- Industry
- FITB Major Banks
- PODD Medical/Dental Instruments
- Sector
- FITB Finance
- PODD Health Care
- Exchange
- FITB Nasdaq
- PODD Nasdaq
- Market Cap
- FITB 25.6B
- PODD 23.8B
- IPO Year
- FITB N/A
- PODD 2007
- Fundamental
- Price
- FITB $45.91
- PODD $322.22
- Analyst Decision
- FITB Buy
- PODD Strong Buy
- Analyst Count
- FITB 14
- PODD 18
- Target Price
- FITB $48.07
- PODD $334.50
- AVG Volume (30 Days)
- FITB 4.1M
- PODD 568.2K
- Earning Date
- FITB 10-17-2025
- PODD 11-06-2025
- Dividend Yield
- FITB 3.22%
- PODD N/A
- EPS Growth
- FITB 2.27
- PODD N/A
- EPS
- FITB 3.21
- PODD 3.32
- Revenue
- FITB $7,993,000,000.00
- PODD $2,359,500,000.00
- Revenue This Year
- FITB $15.38
- PODD $29.18
- Revenue Next Year
- FITB $4.72
- PODD $18.09
- P/E Ratio
- FITB $14.32
- PODD $96.84
- Revenue Growth
- FITB N/A
- PODD 26.00
- 52 Week Low
- FITB $32.25
- PODD $225.37
- 52 Week High
- FITB $49.07
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- FITB 63.10
- PODD 43.19
- Support Level
- FITB $44.50
- PODD $336.00
- Resistance Level
- FITB $45.79
- PODD $351.94
- Average True Range (ATR)
- FITB 0.77
- PODD 10.05
- MACD
- FITB -0.10
- PODD -3.32
- Stochastic Oscillator
- FITB 67.14
- PODD 22.31
About FITB Fifth Third Bancorp
Fifth Third Bancorp is a diversified financial-services company headquartered in Cincinnati. The company has over $210 billion in assets and operates numerous full-service banking branches and ATMs throughout Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, and North Carolina.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.